Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Cochrane Database Syst Rev ; 5: CD012506, 2018 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-29845610

RESUMEN

BACKGROUND: Malignant gastric outlet obstruction is the clinical and pathological consequence of cancerous disease causing a mechanical obstruction to gastric emptying. It usually occurs when malignancy is at an advanced stage; therefore, people have a limited life expectancy. It is of paramount importance to restore oral intake to improve quality of life for the person in a manner that has a minimal risk of complications and a short recovery period. OBJECTIVES: To assess the benefits and harms of endoscopic stent placement versus surgical palliation for people with symptomatic malignant gastric outlet obstruction. SEARCH METHODS: In May 2018 we searched the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, Ovid Embase and Ovid CINAHL. We screened reference lists from included studies and review articles. SELECTION CRITERIA: We included randomised controlled trials comparing stent placement with surgical palliation for people with gastric outlet obstruction secondary to malignant disease. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted study data. We calculated the risk ratio (RR) with 95% confidence intervals (CI) for binary outcomes, mean difference (MD) or standardised mean difference (SMD) with 95% CI for continuous outcomes and the hazard ratio (HR) for time-to-event outcomes. We performed meta-analyses where meaningful. We assessed the quality of evidence using GRADE criteria. MAIN RESULTS: We identified three randomised controlled trials with 84 participants. Forty-one participants underwent surgical palliation and 43 participants underwent duodenal stent placement. There may have been little or no difference in the technical success of the procedure (RR 0.98, 95% CI 0.88 to 1.09; low-quality evidence), or whether the time to resumption of oral intake was quicker for participants who had undergone duodenal stent placement (MD -3.07 days, 95% CI -4.76 to -1.39; low-quality evidence).Due to very low-quality evidence, we were uncertain whether surgical palliation improved all-cause mortality and median survival postintervention.The time to recurrence of obstructive symptoms may have increased slightly following duodenal stenting (RR 5.08, 95% CI 0.96 to 26.74; moderate-quality evidence).Due to very low-quality evidence, we were uncertain whether surgical palliation improved serious and minor adverse events. The heterogeneity for adverse events was moderately high (serious adverse events: Chi² = 1.71; minor adverse events: Chi² = 3.08), reflecting the differences in definitions used and therefore, may have impacted the outcomes. The need for reintervention may have increased following duodenal stenting (RR 4.71, 95% CI 1.36 to 16.30; very low-quality evidence).The length of hospital stay may have been shorter (by approximately 4 to 10 days) following stenting (MD -6.70 days, 95% CI -9.41 to -3.98; moderate-quality evidence). AUTHORS' CONCLUSIONS: The use of duodenal stent placement in malignant gastric outlet obstruction has the benefits of a quicker resumption of oral intake and a reduced inpatient hospital stay; however, this is balanced by an increase in the recurrence of symptoms and the need for further intervention.It is impossible to draw further conclusions on these and the other measured outcomes, primarily due to the low number of eligible studies and small number of participants which resulted in low-quality evidence. It was not possible to analyse the impact on quality of life each intervention had for these participants.


Asunto(s)
Duodeno , Obstrucción de la Salida Gástrica/cirugía , Neoplasias Gastrointestinales/complicaciones , Cuidados Paliativos/métodos , Stents , Adulto , Ingestión de Alimentos , Obstrucción de la Salida Gástrica/etiología , Obstrucción de la Salida Gástrica/mortalidad , Humanos , Tiempo de Internación , Ensayos Clínicos Controlados Aleatorios como Asunto , Recurrencia , Stents/estadística & datos numéricos , Factores de Tiempo
2.
Expert Rev Mol Diagn ; 18(3): 245-258, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29431541

RESUMEN

INTRODUCTION: Cancer is responsible for an extraordinary burden of disease, affecting 90.5 million people worldwide in 2015. Outcomes for these patients are improved when the disease is diagnosed at an early, or even precancerous, stage. Raman spectroscopy is demonstrating results that show its ability to detect the molecular changes that are diagnostic of precancerous and cancerous tissue. This review highlights the new advances occurring in this domain. Areas covered: PubMed searches were undertaken to identify new research in the utilisation of Raman spectroscopy in cancer diagnostics. The areas in which Raman spectroscopy is showing promise are covered, including improving the accuracy of identifying precancerous changes, using the technology in real time, in vivo modalities, the search for a biomarker to aid potential screening and predicting the response of the cancer to the treatment regimen. Expert commentary: Many of the examples in this review are focused on Barrett's oesophagus and oesophageal adenocarcinoma as this is my area of expertise and perfectly exemplifies where Raman spectroscopy could be utilised in clinical practise. The authors discuss the areas where they believe current knowledge is lacking and how Raman spectroscopy could answer the dilemmas that are still faced in the management of cancer.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Técnicas de Diagnóstico Molecular/métodos , Neoplasias/diagnóstico por imagen , Espectrometría Raman/métodos , Biomarcadores de Tumor/genética , Humanos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patología
3.
Future Oncol ; 13(26): 2363-2382, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29121775

RESUMEN

To improve outcomes for patients with cancer, in terms of both survival and a reduction in the morbidity and mortality that results from surgical resection and treatment, there are two main areas that require improvement. Accurate early diagnosis of the cancer, at a stage where curative and, ideally, minimally invasive treatment is achievable, is desired as well as identification of tumor margins, lymphatic and distant disease, enabling complete, but not unnecessarily extensive, resection. Optical imaging is making progress in achieving these aims. This review discusses the principles of optical imaging, focusing on fluorescence and spectroscopy, and the current research that is underway in GI tract carcinomas.


Asunto(s)
Procedimientos Quirúrgicos del Sistema Digestivo , Neoplasias Gastrointestinales/diagnóstico por imagen , Neoplasias Gastrointestinales/cirugía , Imagen Óptica , Cirugía Asistida por Computador , Animales , Medios de Contraste , Diagnóstico Diferencial , Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Humanos , Imagen Óptica/métodos , Cirugía Asistida por Computador/métodos
4.
Int J Surg Case Rep ; 20: 130-2, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26855074

RESUMEN

We describe a case of pseudomyxoma peritonei presenting as a strangulated inguinal hernia. We review the current literature regarding the incidence of underlying pathology in patients presenting with abdominal wall herniae and discuss the need for histological assessment of the hernia sac in selected patients. We highlight the importance of assessing for and being aware of significant underlying pathology in certain patients.

5.
Br J Hosp Med (Lond) ; 75(12): 698-702, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25488533

RESUMEN

Acute pancreatitis is seen commonly on the surgical take. It can be complicated by the development of pseudocysts and necrosis. This review discusses each of these in turn and outlines the different management strategies now on offer.


Asunto(s)
Seudoquiste Pancreático/diagnóstico , Seudoquiste Pancreático/terapia , Pancreatitis/complicaciones , Pancreatitis/terapia , Enfermedad Aguda , Humanos , Necrosis , Seudoquiste Pancreático/etiología , Pancreatitis/patología
6.
BMJ Case Rep ; 20132013 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-23563685

RESUMEN

A man in his late 70s, on hormonal treatment for prostatic adenocarcinoma, presented with bilateral enlarged and painful testes. Bilateral orchidectomy was undertaken and subsequent histological examination revealed both testes completely infiltrated with metastatic prostatic carcinoma.


Asunto(s)
Adenocarcinoma/secundario , Neoplasias de la Próstata/patología , Neoplasias Testiculares/secundario , Adenocarcinoma/cirugía , Anciano , Diagnóstico Diferencial , Humanos , Masculino , Orquiectomía , Neoplasias Testiculares/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...